R&D News | pharmaphorum

News

Packaged Pills in aluminium blisters stacked on each other

Seven future blockbuster drugs to look out for in 2019

AbbVie’s rheumatoid arthritis drug upadacitinib is at the top of a new list of drugs due to launch this year that are expected to make blockbuster sales by 2023.

News

Cell Mogrify gets £420k funding for regenerative cell therap...

UK cell therapy company Cell Mogrify has been awarded £420,000 funding from Innovate UK to accelerate its data-driven cell conversion programmes.

News

Lixiana hits the mark in catheter ablation trial

Daiichi Sankyo’s Lixiana was a late entrant to the novel oral anticoagulant (NOAC) category, but the Japanese drugmaker hopes new data in atrial fibrillation (AFib) could accelerate its gro

News

Karuna raises $68m to develop neurology drug KarXT

Karuna Therapeutics has raised $68 million to further develop its neurology drug KarXT, which is in phase 2 clinical development for acute psychosis in patients with schizophrenia.

News

Beautiful woman using tissue while sneezing in park

Allergy Therapeutics suffers phase 3 birch allergy jab trial...

UK-based Allergy Therapeutics has suffered a setback after phase 3 results from the B301 trial of its latest birch allergy product failed to reduce symptoms.

News

Imara raises $63m for sickle cell drug trials

US biotech Imara has raised $63 million for clinical development of its sickle cell disease drug, which is in mid-stage development.

Seven future blockbuster drugs to look out for in 2019

Cell Mogrify gets £420k funding for regenerative cell therap...

Lixiana hits the mark in catheter ablation trial

Karuna raises $68m to develop neurology drug KarXT

Allergy Therapeutics suffers phase 3 birch allergy jab trial...

Imara raises $63m for sickle cell drug trials

AZ boosts vaccine capabilities with Omniose buy

Securing your ROI: Turning post-acquisition integration into...

News

Editor's Picks